Machine learning can identify newly diagnosed patients with Chronic Lymphocytic Leukemia (CLL) at high risk of infection
Join the Cambridge Centre for AI in Medicine on 2 November at 4pm GMT for a virtual talk and live audience Q&A with Dr. Carsten Utoft Niemann of Rigshospitalet, a centre of expertise for the treatment of blood diseases in Copenhagen, Denmark.
Dr. Niemann is an expert in hematology with more than 10 years hands-on experience in research laboratories in Europe and America. He is currently Associate Professor and Head of the Chronic Lymphocytic Leukemia (CLL) Laboratory and Clinical Research Program for CLL at Rigshospitalet's Dept. of Hematology. Furthermore, he is a sponsor of the PreVent-ACaLL phase 2-3 trial – the first Machine Learning-based clinical trial in CLL.